
Pamorelin LA 11.25mg Powder for Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Triptorelin (11.25mg)
Overview Pamorelin LA 11.25mg Powder for Injection
Triptorelin LA 11.25mg injectable powder treats prostate cancer, excessive uterine endometrial growth (endometriosis) causing pain and irregular bleeding, and premature puberty. Administered subcutaneously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can have severe consequences. Benefits may take weeks or months to appear; discontinue only under medical supervision. Common side effects include hot flushes, weakness, diaphoresis, tiredness, backache, and impotence. Prolonged use might weaken bones; calcium and vitamin D supplements are recommended. Amenorrhea (absence of menstruation) for 7-12 weeks is possible; report persistent bleeding. Disclose any history of alcohol consumption, smoking, or bone fragility before starting treatment. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.
Uses of Pamorelin LA 11.25mg Powder for Injection
Malignancy of the prostate gland | Uterine endometriosis | Accelerated sexual maturation
Major Benefits of Pamorelin LA 11.25mg Powder for Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Pamorelin LA 11.25mg Powder for Injection:
- Weakness
- Increased sweating
- Back pain
- Paresthesia (tingling or pricking sensation)
- Hot flashes
- Erectile dysfunction
How to use Pamorelin LA 11.25mg Powder for Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Pamorelin LA 11.25mg Powder for Injection works:
Pamorelin LA 11.25mg injectable powder lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves reducing circulating testosterone in males. In females, it suppresses ovarian hormone synthesis, thereby decreasing estrogen levels and consequently impacting menstruation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Pamorelin LA 11.25mg Powder for Injection is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Pamorelin LA 11.25mg Powder for Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in animal and human studies indicates considerable adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Pamorelin LA 11.25mg injectable powder while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Pamorelin LA 11.25mg injectable powder can induce adverse reactions that might impair driving. These may include dizziness, fatigue, or visual disturbances like blurred vision, potentially affecting driving capabilities.
KidneyCAUTION
Patients with impaired kidney function should use Pamorelin LA 11.25mg Powder for Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Pamorelin LA 11.25mg Powder for Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Pamorelin LA 11.25mg Powder for Injection :
Should you forget a scheduled Pamorelin LA 11.25mg injectable powder dose, seek immediate medical advice.
Facts to Know About Pamorelin LA 11.25mg Powder for Injection
| Label | Value |
|---|---|
| Chemical Type | Amino acid chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | GnRH agonists and analogs |
